Profiel
Dr. Stephen Hurd, MD MBA, is Venture Partner at TEXO Ventures LLC since 2012.
Dr. Hurd received a BA in science with highest honors from the University of Texas at Austin and was a member of the Phi Beta Kappa and Phi Kappa Phi societies.
He then received an MD from Baylor University in Houston and went on to complete his residency training in internal medicine in Houston and became board certified shortly thereafter.
He received an MBA from St. Edward's University
Eerdere bekende functies van Stephen Hurd
| Bedrijven | Functie | Einde |
|---|---|---|
TEXO Ventures LLC
TEXO Ventures LLC Investment ManagersFinance TEXO Ventures invests in companies located in the United States. The firm targets companies operating in the fields of health IT & technology enabled health services, managed care & benefit design, medical devices & diagnostics and personalized medicine technology. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 31-12-2019 |
Opleiding van Stephen Hurd
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Edward's University
St. Edward's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TEXO Ventures LLC
TEXO Ventures LLC Investment ManagersFinance TEXO Ventures invests in companies located in the United States. The firm targets companies operating in the fields of health IT & technology enabled health services, managed care & benefit design, medical devices & diagnostics and personalized medicine technology. It provides financing for seed and early stage capital requirements. | Finance |
















